Related Experiment Video

Updated: Mar 22, 2026

Inguinal Subcutaneous White Adipose Tissue ISWAT Transplantation Model of Murine Islets
10:14

Inguinal Subcutaneous White Adipose Tissue ISWAT Transplantation Model of Murine Islets

Published on: February 16, 2020

7.0K

Continuous subcutaneous insulin infusion therapy for Type 1 diabetes mellitus in children

M Mavinkurve1, A Quinn2, C S O'Gorman3,4

  • 1Department of Paediatric Endocrinology, Our Lady's Children's Hospital Crumlin, Dublin, Ireland.

Irish Journal of Medical Science
|April 17, 2016
PubMed

Insights

Continuous subcutaneous insulin pump therapy (CSII) offers optimized diabetes management for children with Type 1 diabetes mellitus (T1DM). Understanding CSII principles is crucial for healthcare professionals caring for these young patients.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Diabetes Technology

Background:

  • Continuous subcutaneous insulin pump therapy (CSII) is a recognized treatment for pediatric Type 1 diabetes mellitus (T1DM).
  • Pump therapy enhances glycemic control and lifestyle flexibility in children.
  • Guidelines recommend CSII as a best practice for pediatric diabetes management.

Purpose of the Study:

  • To review the fundamental principles of CSII.
  • To focus on the practical management aspects of insulin pump therapy in children.
  • To ensure healthcare professionals are familiar with CSII management for pediatric T1DM.

Main Methods:

  • This study employed a narrative review methodology.
  • The review synthesized information on basic CSII principles.
  • Practical management considerations for pediatric pump therapy were highlighted.

Main Results:

  • Effective insulin pump management relies on understanding key principles.
  • These principles are essential for optimizing diabetes care in children.
  • CSII offers a flexible approach to managing T1DM in pediatric populations.

Conclusions:

  • Healthcare professionals must be knowledgeable about insulin pump management principles.
  • Familiarity with CSII is vital for comprehensive care of children with T1DM.
  • This review provides essential information for clinicians managing pediatric CSII therapy.
Abstract

Keywords:
Continuous subcutaneous insulin infusionInsulin Pump TherapyPaediatricsType 1 diabetes mellitus

More Related Videos

Pancreatic Duct Infusion: An Effective and Selective Method of Drug and Viral Delivery06:03

Pancreatic Duct Infusion: An Effective and Selective Method of Drug and Viral Delivery

Published on: September 30, 2021

5.7K
Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.2K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.9K
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
1.1K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
713
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
334
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices01:28

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
108